EXTENSIVE METABOLIZERS OF DEBRISOQUINE BECOME POOR METABOLIZERS DURING QUINIDINE TREATMENT

被引：100
作者：
BROSEN, K
GRAM, LF
HAGHFELT, T
BERTILSSON, L
机构：
[1] ODENSE UNIV HOSP,DEPT CARDIOL,DK-5000 ODENSE,DENMARK
[2] KAROLINSKA INST,HUDDINGE HOSP,DEPT CLIN PHARMACOL,S-14186 HUDDINGE,SWEDEN
来源：
PHARMACOLOGY & TOXICOLOGY | 1987年 / 60卷 / 04期
关键词：
D O I：
10.1111/j.1600-0773.1987.tb01758.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：312 / 314
页数：3
相关论文
共 25 条
[1]   SPARTEINE OXIDATION IS PRACTICALLY ABOLISHED IN QUINIDINE-TREATED PATIENTS [J].
BRINN, R ;
BROSEN, K ;
GRAM, LF ;
HAGHFELT, T ;
OTTON, SV .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 22 (02) :194-197
[2]   IMIPRAMINE DEMETHYLATION AND HYDROXYLATION - IMPACT OF THE SPARTEINE OXIDATION PHENOTYPE [J].
BROSEN, K ;
OTTON, SV ;
GRAM, LF .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 40 (05) :543-549
[3]   SPARTEINE OXIDATION POLYMORPHISM - A FAMILY STUDY [J].
BROSEN, K ;
OTTON, SV ;
GRAM, LF .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 21 (06) :661-667
[4]   STEADY-STATE CONCENTRATIONS OF IMIPRAMINE AND ITS METABOLITES IN RELATION TO THE SPARTEINE DEBRISOQUINE POLYMORPHISM [J].
BROSEN, K ;
KLYSNER, R ;
GRAM, LF ;
OTTON, SV ;
BECH, P ;
BERTILSSON, L .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 30 (06) :679-684
[5]  
DISTLERATH LM, 1985, J BIOL CHEM, V260, P9057
[6]   DEFECTIVE N-OXIDATION OF SPARTEINE IN MAN - NEW PHARMACOGENETIC DEFECT [J].
EICHELBAUM, M ;
SPANNBRUCKER, N ;
STEINCKE, B ;
DENGLER, HJ .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (03) :183-187
[7]   A FAMILY AND POPULATION STUDY OF THE GENETIC-POLYMORPHISM OF DEBRISOQUINE OXIDATION IN A WHITE BRITISH-POPULATION [J].
EVANS, DAP ;
MAHGOUB, A ;
SLOAN, TP ;
IDLE, JR ;
SMITH, RL .
JOURNAL OF MEDICAL GENETICS, 1980, 17 (02) :102-105
[8]   HUMAN-LIVER CYTOCHROMES-P-450 INVOLVED IN POLYMORPHISMS OF DRUG OXIDATION [J].
GUENGERICH, FP ;
DISTLERATH, LM ;
REILLY, PEB ;
WOLFF, T ;
SHIMADA, T ;
UMBENHAUER, DR ;
MARTIN, MV .
XENOBIOTICA, 1986, 16 (05) :367-378
[9]   A HUMAN CYTOCHROME-P-450 CHARACTERIZED BY INHIBITION STUDIES AS THE SPARTEINE DEBRISOQUINE MONOOXYGENASE [J].
INABA, T ;
NAKANO, M ;
OTTON, SV ;
MAHON, WA ;
KALOW, W .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1984, 62 (07) :860-862
[10]   QUINIDINE - POTENT INHIBITION OF SPARTEINE AND DEBRISOQUINE OXIDATION INVIVO [J].
INABA, T ;
TYNDALE, RE ;
MAHON, WA .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 22 (02) :199-200
123